BioSig Technologies Sets Sights on Regulated RWA Tokenization with Broker-Dealer Acquisition
Los Angeles, July 14, 2025 – In a landmark move for its business strategy, BioSig Technologies, Inc. (NASDAQ: BSGM) has taken significant steps to establish itself as a pioneer in the tokenization of Real-World Assets (RWA) on major U.S. exchanges. The company, which has recently merged with Streamex Exchange Corporation, has announced that it has engaged Compliance Exchange Group (CXG) to facilitate the purchase of a broker-dealer that is registered with both FINRA and the SEC. This initiative aims to provide robust infrastructure for a gold-backed asset trading platform aimed at institutional and retail investors across the U.S.
The company’s visionary approach targets tapping into the enormous $22 trillion global gold market, situated within the broader $142 trillion commodities sector. This strategic acquisition is not only about compliance; it’s about bridging the gap between traditional finance and the innovative world of blockchain technology. Investors will soon have the opportunity to buy fractional shares of gold through digital tokens, which mirrors the ease of cryptocurrency transactions, thereby creating new avenues for capital raising for businesses.
Henry McPhie, CEO of BioSig and Co-Founder of Streamex, emphasized the transformative significance of this acquisition, stating, “This will be a pivotal moment for both Streamex and BioSig. Obtaining a regulated broker-dealer is crucial as we aim to lead the gold tokenization sector in the U.S. By integrating our Nasdaq listing with a gold-backed platform, we expect to open unprecedented opportunities for investors, potentially reshaping the entire gold market.”
Supporting this vision, Morgan Lekstrom, Executive Chairman, underscored the relevance of gold tokenization in modern commodity finance, stating, “Streamex’s regulatory framework and its presence in the public market position it as a frontrunner in this transformative market, which could redefine access to real assets for investors.”
The strategic acquisition of a FINRA and SEC-registered broker-dealer will create a legal foundation for Streamex to issue and trade tokenized assets, compliant with federal securities regulations. CXG, a recognized leader in broker-dealer compliance, will manage this acquisition, ensuring it aligns with regulatory standards and facilitates seamless integration into the existing framework of the Streamex platform.
Streamex is committed to building a comprehensive on-chain commodity market focused on RWA tokenization. With a goal of becoming a significant public holder of gold bullion listed on Nasdaq, Streamex aims to innovate by combining the traditional security associated with physical gold and the efficiency of blockchain technology, thereby setting the stage for a new era of financial infrastructure in digital commodities.
In aligning their balance sheet predominantly with vaulted gold assets instead of fiat currency, Streamex is not just reshaping its operational strategy; it is also laying the groundwork for a sustainable, value-oriented financial model. This approach is complemented by its Solana-based blockchain, which supports the replication of a revenue model through gold-backed digital asset issuance.
As BioSig Technologies progresses with this strategy, it aims to redefine investment within the global commodities market, promising significant impacts on how investors access and manage real-world assets in a digital format.
About Compliance Exchange Group (CXG)
CXG specializes in constructing and supervising broker-dealer frameworks, offering comprehensive compliance services and guidance.
About BioSig Technologies, Inc.
BioSig Technologies is a medical device firm that has developed the PURE EP Platform, enhancing real-time signal processing for electrophysiological treatments addressing cardiovascular arrhythmias. This advanced technology helps practitioners obtain clear signal data to improve procedural outcomes and efficiency.
This announcement contains forward-looking statements as defined by the Private Securities Litigation Reform Act. These projections are based on certain assumptions and come with various risks that may lead actual results to differ. The company does not commit to updating these statements unless legally required to do so.
